SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q2 2021 Earnings Conference Call August 04, 2021 04:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Jim Kelly - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals' Second Quarter 2021 Financial Results Conference Call. At this time, all participants are on a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo, of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin. Peter Vozzo Thank you, Josh. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals second quarter 2021 financial results conference call. Today, after the close of the market,
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call Transcript